Department of Anesthesiology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
J Obstet Gynaecol. 2024 Dec;44(1):2393379. doi: 10.1080/01443615.2024.2393379. Epub 2024 Aug 21.
Spinal anaesthesia is a common anaesthetic method for caesarean sections but often results in hypotension, posing potential risks to maternal and neonatal health. Norepinephrine, as a vasopressor, may be effective in preventing and treating this hypotension. This systematic review and meta-analysis aims to systematically evaluate the efficacy and safety of prophylactic norepinephrine infusion for the treatment of hypotension following spinal anaesthesia in caesarean sections.
Literature searches were conducted in PubMed, Embase, Web of Science, Cochrane Library, CNKI, Wanfang, and VIP databases for relevant studies on prophylactic administration of norepinephrine for the treatment of hypotension after spinal anaesthesia in caesarean delivery. Reference lists of included articles were also searched. The latest search update was on March 20, 2024. Meta-analysis was conducted using R software. The methods recommended by the Cochrane Handbook, Begge's and Egger's tests were used for risk of bias evaluation of the included literature.
Nine studies were finally included in this study. The results showed that prophylactic administration of norepinephrine was superior to the control group in four aspects of treating hypotension after spinal anaesthesia in caesarean delivery: the incidence of hypotension was reduced [RR = 0.34, 95%CI (0.27-0.43), < 0.01]; the incidence of severe hypotension was reduced [RR = 0.32, 95%CI (0.21-0.51), < 0.01]; and maternal blood pressure was more stable with MDPE [MD = -5.00, 95%CI (-7.80--2.21), 0.06] and MDAPE [MD = 4.11, 95%CI (1.38-6.85), < 0.05], the incidence of nausea and vomiting was reduced [RR = 0.52, 95%CI (0.35-0.77), < 0.01]. On the other hand, the incidence of reactive hypertension was higher than the control group [RR = 3.58, 95%CI (1.94-6.58), < 0.01]. There was no difference between the two groups in one aspects: newborn Apgar scores [MD = -0.01, 95%CI (-0.10-0.09, = 0.85)].
Prophylactic administration of norepinephrine is effective in treating hypotension after spinal anaesthesia in caesarean delivery patients; however, it does not provide improved safety and carries a risk of inducing reactive hypertension.
椎管内麻醉是剖宫产的常用麻醉方法,但常导致低血压,对母婴健康构成潜在风险。去甲肾上腺素作为血管加压药,可能对预防和治疗这种低血压有效。本系统评价和荟萃分析旨在系统评估预防性输注去甲肾上腺素治疗剖宫产椎管内麻醉后低血压的疗效和安全性。
检索 PubMed、Embase、Web of Science、Cochrane 图书馆、CNKI、万方和 VIP 数据库中有关剖宫产椎管内麻醉后预防性应用去甲肾上腺素治疗低血压的相关研究,并检索纳入文献的参考文献列表。最新检索日期为 2024 年 3 月 20 日。使用 R 软件进行荟萃分析。采用 Cochrane 手册推荐的方法、贝格检验和埃格检验对纳入文献的偏倚风险进行评价。
最终纳入 9 项研究。结果显示,与对照组相比,预防性应用去甲肾上腺素在以下四个方面治疗剖宫产椎管内麻醉后低血压更具优势:低血压发生率降低[RR=0.34,95%CI(0.27-0.43), < 0.01];严重低血压发生率降低[RR=0.32,95%CI(0.21-0.51), < 0.01];产妇血压更稳定,MDPE[MD=-5.00,95%CI(-7.80--2.21), 0.06]和 MDAPE[MD=4.11,95%CI(1.38-6.85), < 0.05];恶心呕吐发生率降低[RR=0.52,95%CI(0.35-0.77), < 0.01]。另一方面,去甲肾上腺素组反应性高血压发生率高于对照组[RR=3.58,95%CI(1.94-6.58), < 0.01]。两组新生儿 Apgar 评分无差异[MD=-0.01,95%CI(-0.10-0.09, = 0.85)]。
预防性应用去甲肾上腺素治疗剖宫产椎管内麻醉后低血压有效,但不能提高安全性,且有诱发反应性高血压的风险。